Retraction Retraction dated 2024-08-01
Click to view Retraction: https://doi.org/10.1186/s13148-024-01715-w
-
Authors
Li, Yi
Mao, Xia
Li, Mengyuan
Li, Li
Tong, Xiwen
Huang, Lifang
-
Clinical Trials BETA
Clinical trials referenced in this document:
chictr2000037928 at Chinese Clinical Trial RegistryDocuments that mention this clinical trial
RETRACTED ARTICLE: The predictive value of BTG1 for the response of newly diagnosed acute myeloid leukemia to decitabine
https://doi.org/10.1186/s13148-024-01627-9
-
Funding
Funding for this research was provided by:
The Open Project of Hubei Key Laboratory (2023KFZZ005)
- License Information
-
More Information
Article History
Received: 2 November 2023
Accepted: 11 January 2024
First Online: 22 January 2024
Change Date: 1 August 2024
Change Type: Correction
Change Details: This article has been retracted. Please see the Retraction Notice for more detail:
Change Details: https://doi.org/10.1186/s13148-024-01715-w
Declarations
:
: This study was conducted in accordance with the Declaration of Helsinki and approved by the Medical Ethics Committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology. Written informed consent to participate in this study was provided by the participant/legally authorized representative.
: All authors have agreed to publish this manuscript.
: The authors declare that they have no competing interests.
